A

Arvinas
D

ARVN

13.300
USD
0.92
(7.43%)
مغلق
حجم التداول
71,982
الربح لكل سهم
-3
العائد الربحي
-
P/E
-16
حجم السوق
854,183,110
أصول ذات صلة المقالات

العنوان: Arvinas

القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.